½ÃÀ庸°í¼­
»óǰÄÚµå
1762357

¼¼°èÀÇ Á¦Á¦ °³¹ß ¾Æ¿ô¼Ò½Ì ½ÃÀå, ±Ô¸ð, Á¡À¯À², »ê¾÷ ºÐ¼® º¸°í¼­ : Á¦Á¦º°, ¼­ºñ½ºº°, Ä¡·á ºÐ¾ßº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ¿¹Ãø(2025-2034³â)

Formulation Development Outsourcing Market Size, Share, & Industry Analysis Report: By Formulation, By Service (Preformulation and Formulation Development), By Therapeutic Area, By End Use, and By Region - Market Forecast, 2025-2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 128 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, Á¦Á¦ °³¹ß ¾Æ¿ô¼Ò½Ì ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 835¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·Â°ú ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

Á¦Á¦ °³¹ß ¾Æ¿ô¼Ò½Ì ½ÃÀå¿¡´Â ÀüÀÓ»ó ¹× ÀÓ»ó ´Ü°èÀÇ Á¦Á¦ Ȱµ¿À» Àü¹® CDMO(Contract Development and Manufacturing Organization) ¶Ç´Â CRO(Contract Research Organization)¿¡ ¾Æ¿ô¼Ò½ÌÇÏ´Â °ÍÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ¼­ºñ½º´Â ƯÈ÷ º¹ÀâÇÏ°í ³­¿ë¼º È­ÇÕ¹°ÀÇ °æ¿ì, Á¦¾à ¹× ¹ÙÀÌ¿À Á¦¾à ȸ»ç°¡ À¯È¿¼ººÐ(API)ÀÇ Àü´Þ, ¾ÈÁ¤¼º ¹× »ýü ÀÌ¿ë·üÀ» ÃÖÀûÈ­ÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº ÀǾàǰ ÆÄÀÌÇÁ¶óÀο¡¼­ ºÐÀÚÀÇ º¹À⼺ Áõ°¡, Ư¼ö Àü´Þ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ºñ¿ë Á¦¾à ÇÏ¿¡¼­ °³¹ß ±â°£ ´ÜÃàÀÇ Çʿ伺 µîÀ¸·Î ÀÎÇØ Áö¼ÓÀûÀ¸·Î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¾Æ¿ô¼Ò½ÌÀº ³ª³ë Á¦Çü, ¼­¹æÇü Ç÷§Æû, ¿ëÇØµµ Çâ»ó ±â¼ú µî ÀÚüÀûÀ¸·Î À¯ÁöÇϱ⿡´Â ºñ¿ëÀÌ ¸¹ÀÌ µå´Â °í±Þ ±â´ÉÀ» ÀÌ¿ëÇÒ ¼ö ÀÖµµ·Ï Çϱâ À§ÇØ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù. Á¦¾à »ê¾÷À» Çü¼ºÇÏ´Â Áß¿äÇÑ Æ®·»µå´Â Á¦Á¦ °³¹ßÀ» ½Å¾à °³¹ß¿¡¼­ »ó¾÷È­¿¡ À̸£´Â ±¤¹üÀ§ÇÑ ¿£µå Åõ ¿£µå ¼­ºñ½º ¸ðµ¨¿¡ ÅëÇÕÇÏ´Â °ÍÀÔ´Ï´Ù. ¶ÇÇÑ, ¿¹Ãø ¸ðµ¨¸µ, ÇÏÀ̽º·çDz ½ºÅ©¸®´×, µ¥ÀÌÅÍ ±â¹Ý Á¦Á¦ ºÐ¼®ÀÇ µµÀÔÀº Á¦Á¦ °áÁ¤ ¹æ½ÄÀ» º¯È­½ÃŰ°í ½ÇÆÐÀ²°ú »çÀÌŬ ŸÀÓÀ» °¨¼Ò½Ã۰í ÀÖ½À´Ï´Ù.

´ÙǰÁ¾ ¼Ò·® »ý»ê ¹× °íµµ·Î ¸ÂÃãÈ­µÈ Á¦Çü¿¡´Â ¹ÎøÇÏ°í ±â¼ú·Â ÀÖ´Â ¾Æ¿ô¼Ò½Ì ÆÄÆ®³Ê°¡ ÇÊ¿äÇÕ´Ï´Ù. ±ÔÁ¦ ´ç±¹ÀÇ °¨½Ã°¡ °­È­µÊ¿¡ µû¶ó °ø±Þ¾÷ü´Â °­·ÂÇÑ QbD ¹× À§Çè ±â¹Ý Á¢±Ù¹ýÀ» äÅÃÇØ¾ß Çϸç, ±× Àü·«Àû °¡Ä¡´Â ´õ¿í Ä¿Áö°í ÀÖ½À´Ï´Ù. µðÁöÅÐÈ­, ¸ðµâÈ­µÈ ¼­ºñ½º Á¦°ø, ½Ç½Ã°£ ¹èÄ¡ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ Á߿伺ÀÌ ³ô¾ÆÁü¿¡ µû¶ó °í°´-°ø±ÞÀÚ °ü°è¸¦ À籸¼ºÇÏ°í ¼º´É ¹× ÄÄÇöóÀ̾𽺠º¥Ä¡¸¶Å·À» ÀçÁ¤ÀÇÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½ÃÀåÀÇ ÁøÈ­´Â °úÇÐÀû Çõ½Å°ú Á¡Á¡ ´õ º¹ÀâÇØÁö´Â Ä¡·á ¹× ±ÔÁ¦ ȯ°æ¿¡¼­ÀÇ ¾÷¹« À¯¿¬¼º¿¡ ´ëÇÑ Àü·«Àû ¿ä±¸°¡ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

Á¦Á¦ °³¹ß ¾Æ¿ô¼Ò½Ì ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

Ä¡·á ºÐ¾ßº°·Î º¸¸é, 2024³â¿¡´Â Á¤¹Ð Á¾¾ç Ä¡·áÁ¦¿¡ ´ëÇÑ ¼ö¿ä ±ÞÁõ°ú ÀÓ»ó ÆÄÀÌÇÁ¶óÀÎÀÇ ºü¸¥ È®Àå ¼Óµµ·Î ÀÎÇØ Á¾¾ç ºÐ¾ß°¡ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

ÃÖÁ¾ ¿ëµµº°·Î´Â Á¤ºÎ ¹× Çмú ±â°ü ºÐ¾ß°¡ Áß°³ ¿¬±¸ ¹× ÃÊ±â ½Å¾à °³¹ß¿¡¼­ÀÇ ¿ªÇÒ È®´ë·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

2024³â¿¡´Â ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ ¹ÙÀÌ¿À ÀǾàǰÀÇ ±â¼ú Çõ½Å°ú Á¦³×¸¯ ÀǾàǰÀÇ ±Þ°ÝÇÑ È®´ë·Î ÀÎÇØ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

ºÏ¹Ì Á¦Á¦ °³¹ß ¾Æ¿ô¼Ò½Ì ½ÃÀåÀº ¹ÙÀÌ¿À º¥Ã³ ÀÚº»ÀÇ ±ÞÁõ¿¡ ÈûÀÔ¾î ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è ÁÖ¿ä ½ÃÀå ±â¾÷À¸·Î´Â Catalent, Charles River Laboratories International, Element, Eurofins Scientific, Intertek Group, Labcorp, Lonza, Recipharma, SGS S.A., Thermo Fisher Scientific, Thermo Fisher Scientific µîÀÌ ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå Á¦Á¦ °³¹ß ¾Æ¿ô¼Ò½Ì ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ÇöȲ
  • Á¦Á¦ °³¹ß ¾Æ¿ô¼Ò½Ì ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
    • ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
  • PESTEL ºÐ¼®
  • Á¦Á¦ °³¹ß ¾Æ¿ô¼Ò½Ì ½ÃÀå °­·ÂÇÔ Æò°¡ µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®

Á¦5Àå Á¦Á¦ °³¹ß ¾Æ¿ô¼Ò½Ì ½ÃÀå : Á¦Á¦º°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • °æ±¸
  • ÁÖ»ç
  • ¿Ü¿ë
  • ±âŸ

Á¦6Àå Á¦Á¦ °³¹ß ¾Æ¿ô¼Ò½Ì ½ÃÀå : ¼­ºñ½ºº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • ó¹æÀü
  • ó¹æ °³¹ß

Á¦7Àå Á¦Á¦ °³¹ß ¾Æ¿ô¼Ò½Ì ½ÃÀå : Ä¡·á ºÐ¾ßº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • Á¾¾çÇÐ
  • °¨¿°Áõ
  • ½Å°æÇÐ
  • Ç÷¾×ÇÐ
  • È£Èí±â
  • ½ÉÇ÷°ü°è
  • ÇǺΰú
  • ±âŸ

Á¦8Àå Á¦Á¦ °³¹ß ¾Æ¿ô¼Ò½Ì ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • Á¦¾àȸ»ç ¹× ¹ÙÀÌ¿ÀÀǾàǰ ±â¾÷
  • Á¤ºÎ±â°ü ¹× Çмú±â°ü
  • ±âŸ

Á¦9Àå Á¦Á¦ °³¹ß ¾Æ¿ô¼Ò½Ì ½ÃÀå : Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
    • Á¦Á¦ °³¹ß ¾Æ¿ô¼Ò½Ì ½ÃÀå Æò°¡ : Áö¿ªº°, 2020-2034³â
  • ºÏ¹Ì
    • ºÏ¹Ì : ¹èÇÕº°, 2020-2034³â
    • ºÏ¹Ì : ¼­ºñ½ºº°, 2020-2034³â
    • ºÏ¹Ì : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ºÏ¹Ì : Ä¡·á ºÐ¾ßº°, 2020-2034³â
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • À¯·´ : ó¹æº°, 2020-2034³â
    • À¯·´ : ¼­ºñ½ºº°, 2020-2034³â
    • À¯·´ : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • À¯·´ : Ä¡·á ºÐ¾ßº°, 2020-2034³â
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³×´ú¶õµå
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : Á¦Á¦º°, 2020-2034³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ¼­ºñ½ºº°, 2020-2034³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : Ä¡·á ºÐ¾ßº°, 2020³â-2034³â
    • Áß±¹
    • Àεµ
    • ¸»·¹À̽þÆ
    • ÀϺ»
    • Àεµ³×½Ã¾Æ
    • Çѱ¹
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Á¦Á¦º°, 2020-2034³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¼­ºñ½ºº°, 2020-2034³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Ä¡·á ºÐ¾ßº°, 2020-2034³â
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : Á¦Á¦º°, 2020-2034³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : ¼­ºñ½ºº°, 2020-2034³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : Ä¡·á ºÐ¾ßº°, 2020-2034³â
    • ¸ß½ÃÄÚ
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«

Á¦10Àå °æÀï ±¸µµ

  • È®´ë¿Í Àμö ºÐ¼®
    • È®´ë
    • Àμö
  • Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³

Á¦11Àå ±â¾÷ °³¿ä

  • Catalent Inc.
  • Charles River Laboratories International, Inc.
  • Element
  • Eurofins Scientific SE
  • Intertek Group plc
  • Labcorp
  • Lonza
  • Recipharm
  • SGS S.A.
  • Thermo Fisher Scientific, Inc.
LSH 25.07.10

The formulation development outsourcing market size is expected to reach USD 83.55 billion by 2034, according to a new study by Polaris Market Research. The report "Formulation Development Outsourcing Market Size, Share, & Industry Analysis Report: By Formulation, By Service (Preformulation and Formulation Development), By Therapeutic Area, By End Use, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The formulation development outsourcing market encompasses the externalization of preclinical and clinical-stage formulation activities to specialized contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs). These services support pharmaceutical and biopharmaceutical companies in optimizing the delivery, stability, and bioavailability of active pharmaceutical ingredients (APIs), particularly for complex and poorly soluble compounds. The market is witnessing sustained growth driven by increasing molecular complexity in drug pipelines, rising demand for specialized delivery systems, and the need for accelerated development timelines under cost constraints. Outsourcing has become essential for enabling access to advanced capabilities such as nanoformulation, sustained-release platforms, and solubility enhancement technologies, which are often cost-prohibitive to maintain in-house. A significant trend shaping the industry is the integration of formulation development into broader end-to-end service models that span from discovery to commercialization. Additionally, the deployment of predictive modeling, high-throughput screening, and data-driven formulation analytics is transforming how formulation decisions are made, reducing failure rates and cycle times.

Industry growth opportunities are expanding in the area of personalized medicine, where small-batch, highly tailored formulations require agile and technologically equipped outsourcing partners. Increasing regulatory scrutiny is pushing providers to adopt robust QbD and risk-based methodologies, further enhancing their strategic value. The growing emphasis on digitalization, modular service delivery, and real-time batch monitoring is expected to reshape client-provider relationships and redefine benchmarks for performance and compliance. The market's evolution is being driven by scientific innovation and the strategic need for operational flexibility in an increasingly complex therapeutic and regulatory landscape.

Formulation Development Outsourcing Market Report Highlights

By therapeutic area, in 2024, the oncology segment held the largest share due to the surge in demand for precision oncology therapeutics and the rapid pace of clinical pipeline expansion.

Based on end use, the government and academic institutes segment is expected to witness the highest CAGR during the forecast period due to their expanding role in translational research and early-stage drug discovery.

In 2024, Asia Pacific held the largest share due to a surge in regional biopharmaceutical innovation and rapidly expanding generics industry.

The North America formulation development outsourcing market is projected to register the highest CAGR during the forecast period, driven by an upsurge in biotech venture capital.

A few global key market players include Catalent Inc.; Charles River Laboratories International, Inc.; Element; Eurofins Scientific SE; Intertek Group plc; Labcorp; Lonza; Recipharm; SGS S.A.; and Thermo Fisher Scientific, Inc.

Polaris Market Research has segmented the market report on the basis of formulation, service, therapeutic area, end use, and region:

By Formulation Outlook (Revenue, USD Billion, 2020-2034)

Oral

Injectable

Topical

Others

By Service Outlook (Revenue, USD Billion, 2020-2034)

Preformulation

Formulation Development

By Therapeutic Area Outlook (Revenue, USD Billion, 2020-2034)

Oncology

Infectious Disease

Neurology

Hematology

Respiratory

Cardiovascular

Dermatology

Others

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Pharmaceutical and Biopharmaceutical Companies

Government and Academic Institutes

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Formulation Development Outsourcing Market Insights

  • 4.1. Formulation Development Outsourcing Market - Market Snapshot
  • 4.2. Formulation Development Outsourcing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growth in Biopharmaceutical and Generic Drug Development
      • 4.2.1.2. Advancements in Formulation Technologies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Intellectual Property (IP) and Data Security Concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Formulation Development Outsourcing Market Power Rating Trends
  • 4.6. Value Chain Analysis

5. Formulation Development Outsourcing Market, by Formulation

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Formulation Development Outsourcing Market, by Formulation, 2020-2034 (USD Billion)
  • 5.3. Oral
    • 5.3.1. Formulation Development Outsourcing Market, by Oral, by Region, 2020-2034 (USD Billion)
  • 5.4. Injectable
    • 5.4.1. Formulation Development Outsourcing Market, by Injectable, by Region, 2020-2034 (USD Billion)
  • 5.5. Topical
    • 5.5.1. Formulation Development Outsourcing Market, by Topical, by Region, 2020-2034 (USD Billion)
  • 5.6. Others
    • 5.6.1. Formulation Development Outsourcing Market, by Others, by Region, 2020-2034 (USD Billion)

6. Formulation Development Outsourcing Market, by Service

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
  • 6.3. Preformulation
    • 6.3.1. Formulation Development Outsourcing Market, by Preformulation, by Region, 2020-2034 (USD Billion)
  • 6.4. Formulation Development
    • 6.4.1. Formulation Development Outsourcing Market, by Formulation Development, by Region, 2020-2034 (USD Billion)

7. Formulation Development Outsourcing Market, by Therapeutic Area

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 7.3. Oncology
    • 7.3.1. Formulation Development Outsourcing Market, by Oncology, by Region, 2020-2034 (USD Billion)
  • 7.4. Infectious Disease
    • 7.4.1. Formulation Development Outsourcing Market, by Infectious Disease, by Region, 2020-2034 (USD Billion)
  • 7.5. Neurology
    • 7.5.1. Formulation Development Outsourcing Market, by Neurology, by Region, 2020-2034 (USD Billion)
  • 7.6. Hematology
    • 7.6.1. Formulation Development Outsourcing Market, by Hematology, by Region, 2020-2034 (USD Billion)
  • 7.7. Respiratory
    • 7.7.1. Formulation Development Outsourcing Market, by Respiratory, by Region, 2020-2034 (USD Billion)
  • 7.8. Cardiovascular
    • 7.8.1. Formulation Development Outsourcing Market, by Cardiovascular, by Region, 2020-2034 (USD Billion)
  • 7.9. Dermatology
    • 7.9.1. Formulation Development Outsourcing Market, by Dermatology, by Region, 2020-2034 (USD Billion)
  • 7.10. Others
    • 7.10.1. Formulation Development Outsourcing Market, by Others, by Region, 2020-2034 (USD Billion)

8. Formulation Development Outsourcing Market, by End Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
  • 8.3. Pharmaceutical and Biopharmaceutical Companies
    • 8.3.1. Formulation Development Outsourcing Market, by Pharmaceutical and Biopharmaceutical Companies, by Region, 2020-2034 (USD Billion)
  • 8.4. Government and Academic Institutes
    • 8.4.1. Formulation Development Outsourcing Market, by Government and Academic Institutes, by Region, 2020-2034 (USD Billion)
  • 8.5. Others
    • 8.5.1. Formulation Development Outsourcing Market, by Others, by Region, 2020-2034 (USD Billion)

9. Formulation Development Outsourcing Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Formulation Development Outsourcing Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. Formulation Development Outsourcing Market - North America
    • 9.3.1. North America: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.3.2. North America: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.3.3. North America: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.3.4. North America: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.3.5. Formulation Development Outsourcing Market - US
      • 9.3.5.1. US: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.3.5.2. US: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.3.5.3. US: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.3.5.4. US: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.3.6. Formulation Development Outsourcing Market - Canada
      • 9.3.6.1. Canada: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.4. Formulation Development Outsourcing Market - Europe
    • 9.4.1. Europe: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.4.2. Europe: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.4.3. Europe: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.4. Europe: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.5. Formulation Development Outsourcing Market - UK
      • 9.4.5.1. UK: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.6. Formulation Development Outsourcing Market - France
      • 9.4.6.1. France: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.4.6.2. France: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.4.6.3. France: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.4.6.4. France: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.7. Formulation Development Outsourcing Market - Germany
      • 9.4.7.1. Germany: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.8. Formulation Development Outsourcing Market - Italy
      • 9.4.8.1. Italy: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.9. Formulation Development Outsourcing Market - Spain
      • 9.4.9.1. Spain: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.10. Formulation Development Outsourcing Market - Netherlands
      • 9.4.10.1. Netherlands: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.11. Formulation Development Outsourcing Market - Russia
      • 9.4.11.1. Russia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.12. Formulation Development Outsourcing Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.5. Formulation Development Outsourcing Market - Asia Pacific
    • 9.5.1. Asia Pacific: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.5. Formulation Development Outsourcing Market - China
      • 9.5.5.1. China: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.5.5.2. China: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.5.5.3. China: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.5.5.4. China: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.6. Formulation Development Outsourcing Market - India
      • 9.5.6.1. India: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.5.6.2. India: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.5.6.3. India: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.5.6.4. India: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.7. Formulation Development Outsourcing Market - Malaysia
      • 9.5.7.1. Malaysia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.8. Formulation Development Outsourcing Market - Japan
      • 9.5.8.1. Japan: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.9. Formulation Development Outsourcing Market - Indonesia
      • 9.5.9.1. Indonesia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.10. Formulation Development Outsourcing Market - South Korea
      • 9.5.10.1. South Korea: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.11. Formulation Development Outsourcing Market - Australia
      • 9.5.11.1. Australia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.12. Formulation Development Outsourcing Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.6. Formulation Development Outsourcing Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.6.5. Formulation Development Outsourcing Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.6.6. Formulation Development Outsourcing Market - UAE
      • 9.6.6.1. UAE: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.6.7. Formulation Development Outsourcing Market - Israel
      • 9.6.7.1. Israel: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.6.8. Formulation Development Outsourcing Market - South Africa
      • 9.6.8.1. South Africa: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.6.9. Formulation Development Outsourcing Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.7. Formulation Development Outsourcing Market - Latin America
    • 9.7.1. Latin America: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.7.5. Formulation Development Outsourcing Market - Mexico
      • 9.7.5.1. Mexico: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.7.6. Formulation Development Outsourcing Market - Brazil
      • 9.7.6.1. Brazil: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.7.7. Formulation Development Outsourcing Market - Argentina
      • 9.7.7.1. Argentina: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.7.8. Formulation Development Outsourcing Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Catalent Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Charles River Laboratories International, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Element
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Eurofins Scientific SE
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Intertek Group plc
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Labcorp
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Lonza
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Recipharm
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. SGS S.A.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Thermo Fisher Scientific, Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦